Mass Spectrometry-Based Multivariate Proteomic Tests for Prediction of Outcomes on Immune Checkpoint Blockade Therapy: The Modern Analytical Approach

The remarkable success of immune checkpoint inhibitors (ICIs) has given hope of cure for some patients with advanced cancer; however, the fraction of responding patients is 15–35%, depending on tumor type, and the proportion of durable responses is even smaller. Identification of biomarkers with str...

Descripción completa

Detalles Bibliográficos
Autores principales: Grigorieva, Julia, Asmellash, Senait, Net, Lelia, Tsypin, Maxim, Roder, Heinrich, Roder, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036840/
https://www.ncbi.nlm.nih.gov/pubmed/32012941
http://dx.doi.org/10.3390/ijms21030838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036840/
https://www.ncbi.nlm.nih.gov/pubmed/32012941
http://dx.doi.org/10.3390/ijms21030838

Ejemplares similares